Immix Biopharma, Inc. Common Stock Share Price
NASDAQ: IMMXHealthcare
Live Immix Biopharma, Inc. Common Stock Share Price Chart
O H L
Immix Biopharma, Inc. Common Stock Performance Overview
Days Range
▼
$12.38Low
$12.73High
Markets Today
| Previous Close | $12.72 |
|---|---|
| Open | $12.73 |
| Volume | 182,300 |
| Day's Range | $12.38 - $12.73 |
| 52W Range | $1.94 - $15.10 |
| Market Cap | $852.75 M |
Historical Performance
| 1M Returns | +7.71 |
|---|---|
| 3M Returns | +45.87 |
| 6M Returns | +34.46 |
| 1Y Returns | +508.61 |
| 5Y Returns | NA |
| 10Y Returns | NA |
Immix Biopharma, Inc. Common Stock Fundamentals
| Market Cap | $852.75 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.55 |
| EPS TTM | $-0.87 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.72 |
| EBITDA | $-29.71 M |
| Profit Margin | N/A |
| Market Cap | $852.75 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.55 |
| EPS TTM | $-0.87 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.72 |
| EBITDA | $-29.71 M |
| Profit Margin | N/A |
Immix Biopharma, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$4.68 M | -$6.72 M | -$7.66 M | -$10.89 M | -$10.80 M | -$12.46 M |
| EBITDA | -$4.64 M | -$6.66 M | -$7.57 M | -$10.84 M | -$10.71 M | -$12.37 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $38.15 K | $58.49 K | $96.99 K | $52.11 K | $91.58 K | $90.99 K |
| Income Before Tax | -$4.53 M | -$6.61 M | -$7.58 M | -$10.68 M | -$10.09 M | -$11.54 M |
| Income Tax Expense | $9.82 K | $8.91 K | $7.72 K | $11.27 K | $0 | $14.32 K |
| Net Income + | -$4.54 M | -$6.62 M | -$7.59 M | -$10.69 M | -$10.09 M | -$11.56 M |
| Net Profit Margin | - | - | - | - | - | - |
Immix Biopharma, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $2.79 K | $2.85 K | $3.31 K | $5.30 K | $5.31 K | $7.16 K |
| Reserve & Surplus | -$79.55 M | -$86.12 M | -$93.71 M | -$104.40 M | -$114.44 M | -$125.99 M |
| Non-Current Liabilities | $991.13 K | $972.34 K | $965.05 K | $933.63 K | $912.34 K | $890.64 K |
| Current Liabilities | $9.31 M | $10.01 M | $10.85 M | $10.11 M | $10.54 M | $9.30 M |
| Total Liabilities | $10.30 M | $10.98 M | $11.82 M | $11.04 M | $11.45 M | $10.19 M |
| Fixed Assets | $2.12 M | $2.23 M | $2.36 M | $2.52 M | $2.43 M | $2.36 M |
| Current Assets | $16.78 M | $12.33 M | $16.58 M | $101.24 M | $92.27 M | $233.79 M |
| Total Assets | $19.89 M | $15.64 M | $20.08 M | $104.84 M | $95.82 M | $239.11 M |
Immix Biopharma, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$4.54 M | -$6.62 M | -$7.59 M | -$10.69 M | -$10.09 M | -$11.56 M |
| Operating Cash Flow | -$1.69 M | -$5.31 M | -$5.91 M | -$11.03 M | -$9.83 M | -$11.74 M |
| Investing Cash Flow | -$67.71 K | -$127.63 K | -$372.46 K | -$6.65 M | -$4.80 M | $2.67 M |
| Financing Cash Flow | $0 | $1.11 M | $10.61 M | $95.67 M | -$37.56 K | $155.28 M |
| Change in Cash | -$1.76 M | -$4.28 M | $4.31 M | $77.98 M | -$14.68 M | $146.24 M |
Immix Biopharma, Inc. Common Stock Return Calculator
The Immix Biopharma, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Immix Biopharma, Inc. Common Stock
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
Popular Stocks
FAQs
What is the share price of Immix Biopharma, Inc. Common Stock today?
Immix Biopharma, Inc. Common Stock (IMMX) share price as of September 18, 2026 is $12.35. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Immix Biopharma, Inc. Common Stock?
Yes, Indian Investors can invest in the Immix Biopharma, Inc. Common Stock (IMMX) Share by opening an international trading account with Angel One.
How can I purchase Immix Biopharma, Inc. Common Stock shares in India?
Purchasing Immix Biopharma, Inc. Common Stock (IMMX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Immix Biopharma, Inc. Common Stock (IMMX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Immix Biopharma, Inc. Common Stock?
Yes, you can purchase fractional shares of Immix Biopharma, Inc. Common Stock (IMMX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Immix Biopharma, Inc. Common Stock?
The market capitalization of Immix Biopharma, Inc. Common Stock on September 18, 2026, is $852.75 M.
In which sector Immix Biopharma, Inc. Common Stock belongs?
Immix Biopharma, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Immix Biopharma, Inc. Common Stock stocks?
In order to invest in Immix Biopharma, Inc. Common Stock (IMMX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
